Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone injection for idiopathic spasmodic flat foot in adolescents
NCT05381558Unknown
- Sponsor
- Assiut University
- Start
- Apr 2021
- Primary completion
- Sep 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label trial of triamcinolone in flatfoot, sponsored by Assiut University. Primary endpoint: American Orthopaedic Foot and Ankle Society Ankle-hindfoot scale at 12 months. Status: unknown.
02
Drugs
triamcinolone
03
Conditions
flatfoot
Beyond the preview
Go deeper on NCT05381558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05381558.